Redhawk Wealth Advisors’s Quest Diagnostics DGX Stock Holding History

Redhawk Wealth Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,388	Closed	-$413K	–	224
2021 Q4	$413K	Buy	+2,388	New	+$363K	0.11%	134
2020 Q3	–	Sell	-1,969	Closed	-$224K	–	218
2020 Q2	$224K	Buy	+1,969	New	+$209K	0.08%	166
2019 Q3	–	Sell	-469	Closed	-$48K	–	199
2019 Q2	$48K	Buy	+469	New	+$45.1K	0.02%	248

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Redhawk Wealth Advisors's DGX Position: Q1 2022 in Review

Redhawk Wealth Advisors sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 2,388 shares — an estimated $413K sold.

Redhawk Wealth Advisors first reported a position in DGX in Q2 2019 and held it in 3 quarters. The position peaked at $413K in Q4 2021. 851 funds tracked by Wall St. Rank hold DGX as of Q1 2022.

Redhawk Wealth Advisors reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
Redhawk Wealth Advisors sold 2,388 Quest Diagnostics shares in Q1 2022, an estimated $413K.
Redhawk Wealth Advisors first reported a position in Quest Diagnostics in Q2 2019 and held it in 3 quarters.
Redhawk Wealth Advisors's Quest Diagnostics position peaked at $413K in Q4 2021.
851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.

Based on Redhawk Wealth Advisors's 13F filing for Q1 2022, filed 21 Apr 2022.